Phase I-II Study of Interferon-gamma in Patients With HER-2 Positive Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Breast Cancer, Male|Breast Cancer Female|HER2-positive Breast Cancer
Interventions: BIOLOGICAL: Interferon-gamma (IFN-γ)|DRUG: Paclitaxel|DRUG: Trastuzumab|OTHER: Pertuzumab|PROCEDURE: Post Therapy Surgery
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Collaborators: Horizon Pharma Ireland, Ltd., Dublin Ireland